Renaissance Technologies’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27
| Closed | -$24K | – | 3609 |
|
|
2024
Q1 | $24K | Buy |
+27
| New | +$18.6K | ﹤0.01% | 3573 |
|
|
2023
Q2 | – | Sell |
-35
| Closed | -$44K | – | 4017 |
|
|
2023
Q1 | $44K | Sell |
35
-12
| -26% | -$18.1K | ﹤0.01% | 3686 |
|
|
2022
Q4 | $56K | Sell |
47
-148
| -76% | -$209K | ﹤0.01% | 3777 |
|
|
2022
Q3 | $360K | Buy |
195
+33
| +20% | +$114K | ﹤0.01% | 3112 |
|
|
2022
Q2 | $629K | Buy |
162
+84
| +108% | +$603K | ﹤0.01% | 3015 |
|
|
2022
Q1 | $1.19M | Buy |
78
+38
| +95% | +$721K | ﹤0.01% | 2616 |
|
|
2021
Q4 | $1.24M | Buy |
+40
| New | +$2.18M | ﹤0.01% | 2490 |
|
|
2021
Q2 | – | Sell |
-3
| Closed | -$74K | – | 3537 |
|
|
2021
Q1 | $74K | Buy |
+3
| New | +$162K | ﹤0.01% | 3236 |
|
|
2020
Q4 | – | Sell |
-7
| Closed | -$167K | – | 3462 |
|
|
2020
Q3 | $167K | Sell |
7
-1
| -13% | -$30.1K | ﹤0.01% | 3143 |
|
|
2020
Q2 | $253K | Buy |
8
+4
| +100% | +$86.9K | ﹤0.01% | 3097 |
|
|
2020
Q1 | $94K | Hold |
4
| – | – | ﹤0.01% | 3239 |
|
|
2019
Q4 | $131K | Hold |
4
| – | – | ﹤0.01% | 3266 |
|
|
2019
Q3 | $193K | Hold |
4
| – | – | ﹤0.01% | 3159 |
|
|
2019
Q2 | $206K | Buy |
4
+1
| +33% | +$52.4K | ﹤0.01% | 3297 |
|
|
2019
Q1 | $201K | Hold |
3
| – | – | ﹤0.01% | 3210 |
|
|
2018
Q4 | $89K | Hold |
3
| – | – | ﹤0.01% | 3245 |
|
|
2018
Q3 | $215K | Hold |
3
| – | – | ﹤0.01% | 3130 |
|
|
2018
Q2 | $216K | Hold |
3
| – | – | ﹤0.01% | 3060 |
|
|
2018
Q1 | $332K | Hold |
3
| – | – | ﹤0.01% | 3041 |
|
|
2017
Q4 | $194K | Hold |
3
| – | – | ﹤0.01% | 3142 |
|
|
2017
Q3 | $265K | Hold |
3
| – | – | ﹤0.01% | 2934 |
|
|
2017
Q2 | $283K | Buy |
3
+1
| +50% | +$108K | ﹤0.01% | 2919 |
|
|
2017
Q1 | $294K | Hold |
2
| – | – | ﹤0.01% | 2911 |
|
|
2016
Q4 | $214K | Buy |
2
+1
| +100% | +$120K | ﹤0.01% | 2984 |
|
|
2016
Q3 | $148K | Hold |
1
| – | – | ﹤0.01% | 3125 |
|
|
2016
Q2 | $158K | Hold |
1
| – | – | ﹤0.01% | 3092 |
|
|
2016
Q1 | $124K | Hold |
1
| – | – | ﹤0.01% | 3178 |
|
|
2015
Q4 | $130K | Hold |
1
| – | – | ﹤0.01% | 3080 |
|
|
2015
Q3 | $268K | Hold |
1
| – | – | ﹤0.01% | 2809 |
|
|
2015
Q2 | $182K | Hold |
1
| – | – | ﹤0.01% | 2999 |
|
|
2015
Q1 | $326K | Hold |
1
| – | – | ﹤0.01% | 2736 |
|
|
2014
Q4 | $345K | Hold |
1
| – | – | ﹤0.01% | 2537 |
|
|
2014
Q3 | $258K | Hold |
1
| – | – | ﹤0.01% | 2512 |
|
|
2014
Q2 | $408K | Hold |
1
| – | – | ﹤0.01% | 2389 |
|
|
2014
Q1 | $481K | Hold |
1
| – | – | ﹤0.01% | 2370 |
|
|
2013
Q4 | $451K | Hold |
1
| – | – | ﹤0.01% | 2385 |
|
|
2013
Q3 | $239K | Hold |
1
| – | – | ﹤0.01% | 2521 |
|
|
2013
Q2 | $274K | Buy |
+1
| New | +$262K | ﹤0.01% | 2427 |
|
Other funds holding ERNA
CPWM
NW
SCA
AWE
BWP
TRCT
Renaissance Technologies's ERNA Position: Q2 2024 in Review
Renaissance Technologies sold out of Eterna Therapeutics (ERNA) in Q2 2024, closing a stake of 27 shares — an estimated $24K sold.
Renaissance Technologies first reported a position in ERNA in Q2 2013 and held it in 38 quarters. The position peaked at $1.24M in Q4 2021. 11 funds tracked by Wall St. Rank hold ERNA as of Q2 2024.
- Renaissance Technologies reported no remaining Eterna Therapeutics position as of Q2 2024 after selling out during the quarter.
- Renaissance Technologies sold 27 Eterna Therapeutics shares in Q2 2024, an estimated $24K.
- Renaissance Technologies first reported a position in Eterna Therapeutics in Q2 2013 and held it in 38 quarters.
- Renaissance Technologies's Eterna Therapeutics position peaked at $1.24M in Q4 2021.
- 11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2024.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.